You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Profile for Argentina Patent: 042806


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 042806

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,759,350 Mar 2, 2027 Otsuka ABILIFY aripiprazole
8,759,350 Mar 2, 2027 Otsuka ABILIFY MYCITE KIT aripiprazole
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of Argentina Drug Patent AR042806: Scope, Claims, and Patent Landscape

Last updated: August 3, 2025


Introduction

The patent AR042806 pertains to a pharmaceutical invention granted in Argentina. Understanding its scope and claims is instrumental for stakeholders across the pharmaceutical industry—ranging from patent attorneys to R&D strategists—aiming to navigate competitive landscapes, ensure patent validity, and manage licensing or infringement risks.

This analysis dissects AR042806’s claims and scope, contextualizes it within Argentina’s patent landscape, and discusses implications for market players.


Patent Overview and Basic Data

AR042806 was granted to protect a specific pharmaceutical formulation or method of use. Although the original patent document details are not fully available here, typical patent characteristics include:

  • Filing date: Provides the priority period.
  • Grant date: Indicates the timeline for patent protection.
  • Patent term: Generally 20 years from filing, subject to maintenance.
  • Patent type: Usually a utility patent covering novel, inventive, and industrially applicable inventions in pharmaceuticals.

Scope of Patent AR042806

The scope of a patent hinges on its claims—the legal boundary outlining what is protected.

Main Claims Analysis

  1. Claim Language and Preamble
    The claims likely specify a pharmaceutical composition, method of synthesis, or administration regimen. The preamble frequently describes the purpose or intended therapeutic effect, for example, "A pharmaceutical composition comprising..."

  2. Claim Dependencies and Types

    • Independent claims: Broad, defining core invention aspects—e.g., a novel molecule or formulation.
    • Dependent claims: Narrower, adding specific features—e.g., particular dosages, excipients, or delivery modes.
  3. Scope Determination
    If the claims specify a novel compound, the scope is limited to that compound and derivatives with similar structure. If they focus on a method of use, the scope extends to certain therapeutic indications or administration techniques.


Claims Content and Protectable Subject Matter

Without access to the precise text, typical scenarios include:

  • Novel compounds or formulations: Protecting specific chemical entities or their pharmaceutical compositions.
  • Method of manufacturing: Novel synthesis processes for active pharmaceutical ingredients (APIs).
  • Method of use: Therapeutic methods for treating particular diseases.
  • Delivery system innovations: Sustained release, targeting mechanisms, or combination therapies.

Given Argentina’s patent law, claims must demonstrate novelty, inventive step, and industrial applicability. If claims encompass a broad genus of compounds or methods, they may be more valuable but also more vulnerable to invalidation if prior art exists.


Patent Landscape in Argentina

Argentina’s patent system aligns with the Patent Cooperation Treaty (PCT) framework, with local laws governed by Law 24,481 and regulations outlined by INPI (Instituto Nacional de Propiedad Industrial).

Key Features of the Patent Landscape

  • Patentability criteria: Similar to other jurisdictions—novelty, inventive step, industrial applicability.
  • Pharmaceutical patent laws: Historically influenced by TRIPS obligations, with explicit exclusions for certain second medical uses, but recent legal reforms have expanded scope.
  • Patent term: 20 years from the filing date, with potential extensions for regulatory delays.
  • Exclusions: Argentina permits patents on new compounds, formulations, and methods of therapeutic use, provided they meet patentability criteria.

Legal and Market Implications

1. Patent Scope and Enforcement
A broad independent claim in AR042806 could afford considerable protection, deterring generic entry for similar formulations or methods. Narrow claims limit enforceability but may face less opposition.

2. Patent Challenges and Invalidations
Prior art searches—especially for chemical and formulation patents—are critical, given Argentina’s evolving patent examination rigor. Competitors may attempt to invalidate the patent based on prior disclosures, obvious modifications, or lack of inventive step.

3. Patent Life and Maintenance
Maintaining AR042806 throughout its life requires timely fee payments. Patent expiry opens the market for generics, which may be significant for drug pricing and access strategies.

4. Patent Landscape Competition
AR042806 exists within a growing occupational field with numerous patents protecting similar therapeutic classes. Patent landscaping involves analyzing other filings to identify overlapping claims, potential for patent fences, or freedom-to-operate opportunities.


Comparative Analysis with Global Patent Landscape

While Argentina's patent system shares similarities with other jurisdictions, notable differences include:

  • Scope of medicinal use claims: Argentina tends to require rigorous novelty in therapeutic methods, sometimes making method claims narrower.
  • patent examination process: Historically less formal than the USPTO or EPO, which can result in broader claims surviving initial examination but being challenged post-grant.

Global patent landscape analysis indicates that pharmaceutical patents similar to AR042806 are prevalent in major markets in the US, Europe, and Asia. Patent families often include counterparts or divisional applications to strengthen protection.


Conclusion

The patent AR042806 appears to encompass a defined scope, likely centered on specific therapeutic formulations or methods, with enforcement potential in Argentina’s pharmaceutical market. Its strength relies heavily on claim breadth and the novelty over prior art.

Stakeholders should conduct comprehensive freedom-to-operate analyses, monitor competing patents, and consider the legal landscape’s nuances to optimize strategic planning around this patent.


Key Takeaways

  • Claim specificity matters: Broader claims offer stronger protection but face higher invalidation risks; narrower claims may be easier to defend.
  • Patent landscape awareness: Understanding related patents enhances strategic positioning and prevents infringement.
  • Legal diligence: Regular patent maintenance and monitoring patent validity ensure ongoing market exclusivity.
  • Regulatory alignment: Patent rights should be synchronized with regulatory approvals for market security.
  • Market implications: Patent lifespan and enforceability influence pricing, licensing, and entry strategies.

FAQs

1. What is the main protective scope of patent AR042806?
The scope depends on its independent claims, likely covering specific pharmaceutical formulations or methods; precise protection hinges on the claim language and patent prosecution history.

2. How do Argentinian patent laws impact pharmaceutical patents like AR042806?
Argentina grants patents based on novelty, inventive step, and industrial applicability, with legal provisions allowing for method and composition claims, aligning with TRIPS standards, but with some regional nuances.

3. Can competitors design around AR042806 without infringement?
Yes, if they develop alternative formulations or methods not covered by the patent claims, especially if the claims are narrowly construed or amended during prosecution.

4. How does the patent landscape influence market entry in Argentina?
A strong patent portfolio can delay generic entry, maintaining higher drug prices; conversely, fragmented or weaker patents can create opportunities for competitors.

5. What strategic actions should patent holders consider regarding AR042806?
Regular patent monitoring, defending against invalidation challenges, considering patent term extensions, and aligning patent strategies with regulatory pathways are crucial.


References

  1. INPI Argentina Patent Laws. https://www.argentina.gob.ar/inpi.
  2. TRIPS Agreement. World Trade Organization.
  3. Patent Law of Argentina (Law 24,481).
  4. Global Patent Landscape Reports. WIPO Patent Landscape Reports.
  5. Pharmaceutical Patent Strategies in Latin America. [Bloomberg Law Reports; 2022].

Note: For specific claim language, legal status, or detailed prosecution history of AR042806, consulting the actual patent document via INPI’s database or legal counsel is recommended.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.